Cipla Limited's Kurkumbh facility gets VAI classification from USFDA

The United States Food and Drug Administration (USFDA) vide communication dated Friday, 12th July, 2024 (10.18 PM IST) has classified Cipla Limited's Kurkumbh manufacturing facility as Voluntary Action Indicated ("VAI") after current Good Manufacturing Practices (cGMP) inspection at the said facility.

Shares of Cipla Limited was last trading in BSE at Rs. 1511.95 as compared to the previous close of Rs. 1505.80. The total number of shares traded during the day was 19057 in over 1556 trades.

The stock hit an intraday high of Rs. 1515.00 and intraday low of 1503.00. The net turnover during the day was Rs. 28789256.00.

Source : Equity Bulls

Keywords

Cipla INE059A01026 KurkumbhFacility USFDA cGMPInspection VAIStatus